DOLBY LABORATORIES, INC. — Net Income by Fiscal Year
18 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8bcbf18f-95cc-4d32-beac-9faec42f15da/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $255.0M | 2024-09-28 – 2025-09-26 | evidence 0001308547-25-000007 |
| FY 2024 | $261.8M | 2023-09-30 – 2024-09-27 | evidence 0001628280-24-048519 |
| FY 2023 | $200.7M | 2022-10-01 – 2023-09-29 | evidence 0001628280-23-039389 |
| FY 2022 | $184.1M | 2021-09-25 – 2022-09-30 | evidence 0001628280-22-030390 |
| FY 2021 | $310.2M | 2020-09-26 – 2021-09-24 | evidence 0001628280-21-023630 |
| FY 2020 | $231.4M | 2019-09-28 – 2020-09-25 | evidence 0001628280-20-016459 |
| FY 2019 | $255.2M | 2018-09-29 – 2019-09-27 | evidence 0001628280-19-014472 |
| FY 2018 | $41.7M | 2017-09-30 – 2018-09-28 | evidence 0001628280-19-014472 |
| FY 2017 | $206.5M | 2016-10-01 – 2017-09-29 | evidence 0001628280-19-014472 |
| FY 2016 | $185.9M | 2015-09-26 – 2016-09-30 | evidence 0001628280-16-021559 |
| FY 2015 | $181.4M | 2014-09-27 – 2015-09-25 | evidence 0001628280-15-008974 |
| FY 2014 | $206.1M | 2013-09-28 – 2014-09-26 | evidence 0001445305-14-005158 |
| FY 2013 | $189.3M | 2012-09-29 – 2013-09-27 | evidence 0001308547-13-000011 |
| FY 2012 | $264.3M | 2011-10-01 – 2012-09-28 | evidence 0001308547-12-000010 |
| FY 2011 | $309.3M | 2010-09-25 – 2011-09-30 | evidence 0001193125-11-320293 |
| FY 2010 | $283.4M | 2009-09-26 – 2010-09-24 | evidence 0001193125-10-266157 |
| FY 2009 | $243.0M | 2008-09-27 – 2009-09-25 | evidence 0001193125-10-266157 |
| FY 2008 | $199.5M | 2007-09-29 – 2008-09-26 | evidence 0001193125-10-266157 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
DOLBY LABORATORIES, INC. — all facts · Revenue · Operating Income